Abstract
Introduction
Bisphosphonate (BF) therapy is strongly related to the occurrence of medication-related osteonecrosis of the jaw (ONJ). However, no previous study has evaluated if there are sex-related differences on the ONJ establishment together with bone biomechanical alterations, and if they could have a synergy with the ZA treatment.
Materials and Methods
This study aimed to analyze the physicochemical properties of mineralized tissues in a zoledronate (ZA)-related osteonecrosis mouse model, by a 2 × 2-factorial design, considering sex (female/male) and treatment (ZA/Saline) factors (n = 8/group). After three ZA (1.0 mg/kg) or saline administrations (days 0, 7, 14), the lower left second molar was extracted (day 42). Further ZA administration (day 49) and euthanasia (day 70) were conducted. After confirmation of ZA-induced jaw necrosis (histologic and microtomographic analysis), spectroscopic and mechanical parameters were assessed.
Results
ZA-treated groups presented lower bone density due to impaired healing of tooth extraction socket. Sex-related alterations were also observed, with lower bone density in females. Regarding biomechanical parameters, sex and treatment exerted independent influences. ZA, although decreasing flexural modulus and yield stress, increases stiffness mainly due to a higher bone volume. Females show less resistance to higher loads compared to males (considering dimension-independent parameters). Additionally, ZA increases crystallinity in bone and dental structure (p < 0.05). In summary, although strongly related to osteonecrosis occurrence, ZA modifies bone and dental mineral matrix, improving bone mechanical properties.
Conclusion
Despite sex-dependent differences in bone biomechanics and density, osteonecrosis was established with no sex influence. No synergistic association between sex and treatment factors was observed in this study.
Similar content being viewed by others
References
Russell RG (2007) Bisphosphonates: mode of action and pharmacology. Pediatrics 119:S150–S162
Weiss HM, Pfaar U, Schweitzer A, Wiegand H, Skerjanec A, Schran H (2008) Biodistribution and plasma protein binding of zoledronic acid. Drug Metab Dispos 36:2043–2049
Hokugo A, Sun S, Park S, McKenna CE, Nishimura I (2013) Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats. Bone 53:59–68
Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N (2009) High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res 15:5829–5839
Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 27:5356–5362
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O´Ryan F (2014) American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update. J Oral Maxillofac Surg 72:1938–1956
Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753–761
Al-Ashqar M, Panteli M, Chakrabarty G, Giannoudis PV (2018) Atypical fractures: an issue of concern or a myth? Injury 49:649–655
Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1–23
Aref MW, McNerny EM, Brown D, Jepsen KJ, Allen MR (2016) Zoledronate treatment has different effects in mouse strains with contrasting baseline bone mechanical phenotypes. Osteoporos Int 27:3637–3643
Lloyd AA, Gludovatz B, Riedel C, Luengo EA, Saiyed R, Marty E, Lorich DG, Lane JM, Ritchie RO, Busse B, Donnelly E (2017) Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance. Proc Natl Acad Sci U S A 114:8722–8727
Juillard A, Falgayrac G, Cortet B, Vieillard MH, Azaroual N, Hornez JC, Penel G (2010) Molecular interactions between zoledronic acid and bone: an in vitro Raman microspectroscopic study. Bone 47:895–904
Yerramshetty JS, Akkus O (2008) The associations between mineral crystallinity and the mechanical properties of human cortical bone. Bone 42:476–482
de Barros Silva PG, Ferreira AEC Jr, de Oliveira CC, Verde M, Freitas MO, Sousa FB, Mota MRL, Alves APNN (2019) Chronic treatment with zoledronic acid alters the expression levels of inflammatory, bone, and apoptotic markers and Toll-like receptors 2 and 4 in rat dental pulp. Oral Surg Oral Med Oral Pathol Oral Radiol 128:139–145
de Barros Silva PG, Verde M, Brizeno LAC, Wong DVT, Lima Junior RCP, Sousa FB, Mota MRL, Alves APNN (2017) Immune cell profile of dental pulp tissue treated with zoledronic acid. Int Endod J 50:1067–1076
Felice PA, Gong B, Ahsan S, Deshpande SS, Nelson NS, Donneys A, Tchanque-Fossuo C, Morris MD, Buchman SR (2015) Raman spectroscopy delineates radiation-induced injury and partial rescue by amifostine in bone: a murine mandibular model. J Bone Miner Metab 33:279–284
Mandair GS, Morris MD (2015) Contributions of Raman spectroscopy to the understanding of bone strength. Bonekey Rep 4:620
Olejnik C, Falgayrac G, During A, Vieillard MH, Maes JM, Cortet B, Penel G (2014) Molecular alterations of bone quality in sequesters of bisphosphonates-related osteonecrosis of the jaws. Osteoporos Int 25:747–756
Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR (2003) Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Calcif Tissue Int 72:519–527
Lisboa MR, Gondim DV, Ervolino E, Vale ML, Frota NP, Nunes NL, Mariguela VC, Taba M Jr, Messora MR, Furlaneto FAC (2015) Effects of electroacupuncture on experimental periodontitis in rats. J Periodontol 86:801–811
Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, Haynatzki GR, Babi P, Allen KM, Yaworsky PJ, Bex F, Recker RR (2004) Bone biomechanical properties in LRP5 mutant mice. Bone 35:162–169
Olejnik C, Falgayrac G, During A, Cortet B, Penel G (2016) Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat’s calvaria defect. Bone 89:32–39
Kuroshima S, Mecano RB, Tanoue R, Koi K, Yamashita J (2014) Distinctive tooth-extraction socket healing: bisphosphonate versus parathyroid hormone therapy. J Periodontol 85:24–33
Scoletta M, Arata V, Arduino PG, Lerda E, Chiecchio A, Gallesio G, Scully C, Mozzati M (2013) Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol. J Oral Maxillofac Surg 71:994–999
Silva PG, Ferreira Junior AE, Teófilo CR, Barbosa MC, Lima Júnior RC, Sousa FB, Mota MRL, Ribeiro RA, Alves APNN (2015) Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis. Arch Oral Biol 60:1237–1245
Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC (2009) Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 45:164–172
Hikita H, Miyazawa K, Tabuchi M, Kimura M, Goto S (2009) Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats. J Bone Miner Metab 27:663–672
Lim SS, Lee B, Kim IS, Hwang SJ (2017) Differential modulation of zoledronate and etidronate in osseous healing of an extracted socket and tibia defect. Oral Surg Oral Med Oral Pathol Oral Radiol 123:8–19
Eckstein F, Matsuura M, Kuhn V, Priemel M, Müller R, Link TM, Lochmuller EM (2007) Sex differences of human trabecular bone microstructure in aging are site-dependent. J Bone Miner Res 22:817–824
Nieves JW (2017) Sex-Differences in Skeletal Growth and Aging. Curr Osteoporos Rep 15:70–75
Popp KL, Hughes JM, Martinez-Betancourt A, Scott M, Turkington V, Caksa S, Guerriere KI, Ackerman KE, Xu C, Unnikrishnan G, Reifman J, Bouxsein ML (2017) Bone mass, microarchitecture and strength are influenced by race/ethnicity in young adult men and women. Bone 103:200–208
Popp KL, Xu C, Yuan A, Hughes JM, Unnikrishnan G, Reifman J, Bouxsein ML (2019) Trabecular microstructure is influenced by race and sex in Black and White young adults. Osteoporos Int 30:201–209
Willinghamm MD, Brodt MD, Lee KL, Stephens AL, Ye J, Silva MJ (2010) Age-related changes in bone structure and strength in female and male BALB/c mice. Calcif Tissue Int 86:470–483
Zhu ED, Louis L, Brooks DJ, Bouxsein ML, Demay MB (2014) Effect of bisphosphonates on the rapidly growing male murine skeleton. Endocrinology 155:1188–1196
Bartlow CM, Oest ME, Mann KA, Zimmerman ND, Butt BB, Damron TA (2017) PTH(1–34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology. J Orthop Res 35:1707–1715
Liu J, Duan Y (2012) Saliva: a potential media for disease diagnostics and monitoring. Oral Oncol 48:569–577
Opsahl Vital S, Gaucher C, Bardet C, Rowe PS, George A, Linglart A, Chaussain C (2012) Tooth dentin defects reflect genetic disorders affecting bone mineralization. Bone 50:989–997
Rani CS, MacDougall M (2000) Dental cells express factors that regulate bone resorption. Mol Cell Biol Res Commun 3:145–152
Caruso S, Bernardi S, Pasini M, Giuca MR, Docimo R, Continenza MA, Gatto R (2016) The process of mineralisation in the development of human tooth. Eur J Paediatr Dent 17:322–326
Buckley K, Matousek P, Parker AW, Goodship AE (2012) Raman spectroscopy reveals differences in collagen secondary structure which relate to the levels of mineralisation in bones that have evolved for different functions. J Raman Spectrosc 43:1237–1243
Acknowledgements
The authors would like to thank the National Council for the Improvement of Higher Education (CAPES) and Central Analítica-UFC/CT-INFRA/MCTI-SISANO/Pró-Equipamentos CAPES for their support. The authors also thank Charles Alves Silva, mechanical engineer, for technical support.
Funding
Brazilian funding agencies CAPES (Coordination of Superior Level Staff Improvement) and CNPq (National Council for Scientific and Technological Development) provided financial support for this research.
Author information
Authors and Affiliations
Contributions
MEQ L-V: conceptualization, investigation, writing—original draft; MIdQR: investigation; BRV: formal analysis, data curation; FTGLVN: formal analysis, data curation; EVHA: formal analysis, data curation; FBdS: formal analysis, data curation; ARP: formal analysis, data curation; PGdBS: formal analysis, data curation; FBS: writing—review and editing, supervision; MRLM: writing—review and editing, supervision; APNNA: conceptualization, methodology, writing—review and editing, supervision, project administration.
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Lima-Verde, M.E.Q., de Queiroz Rodrigues, M.I., Vieira, B.R. et al. Zoledronate treatment exerts sex-independent effects on bone and dental physicochemical properties in mice jaw necrosis. J Bone Miner Metab 41, 760–771 (2023). https://doi.org/10.1007/s00774-023-01465-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-023-01465-4